Sources of patients' knowledge of the adverse effects of psychotropic medication and the perceived influence of adverse effects on compliance among service users attending community mental health services

Journal of Clinical Psychopharmacology

Volumn 29, Issue 6, 2009, Pages 565-570

  Agyapong, Vincent I O ^a   Nwankwo, Vincent ^b   Bangaru, Raju ^c   Kirrane, Rachelle ^c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b St Ita's Hospital   (Ireland)

^c Royal College of Surgeons in Ireland   (Ireland)

Author keywords

Adverse effects; Compliance; Medication; Noncompliance

Indexed keywords

BENZODIAZEPINE; ESCITALOPRAM; FLUOXETINE; LITHIUM; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; TRIFLUOPERAZINE; VENLAFAXINE;

ADULT; ADVERSE OUTCOME; AMNESIA; ANXIETY DISORDER; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; BIPOLAR DISORDER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIZZINESS; DROWSINESS; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EDUCATIONAL STATUS; FEMALE; HUMAN; INTERNET; IRELAND; KIDNEY DISEASE; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; NAUSEA AND VOMITING; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PATIENT INFORMATION; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SIDE EFFECT; SWEATING; TREMOR; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADULT; COMMUNITY MENTAL HEALTH SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PSYCHOTROPIC DRUGS;

EID: 72949124711     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181befa3e     Document Type: Article

References (24)

1. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33(1):67-74.
2. Joseph B. Compliance with treatment in schizophrenia. Hosp Community Psychiatry. 1987;38:55-60.
3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
4. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23:637-651.
5. Donohoe G, Owens N, O'Donnell C, et al. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry. 2001;16:293-298.
6. Grunebaum MF, Weiden PJ, Olfson M. Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study. J Clin Psychiatry. 2001;62:394-399.
7. Weiden P, Rapkin B, Mott T, et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull. 1994;20:297-310.
8. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105(3):164-172.
9. Blackwell B. Treatment adherence. Br J Psychiatry. 1976;129:510-531.
10. Richard B, Managing compliance. Psychiatr Times. 2002;19(5):1-7.
11. Baretz RM, Stephenson GR. The unrealistic patient. N Y State J Med. 1976;76(1):54-57.
12. Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry. 1995;56:4-8.
13. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;63(5):384-390.
14. Ley P. Satisfaction, compliance and communication. Br J Clin Psychol. 1982;21;241-254.
15. Joubert P. Patient package inserts: nature, notions, and needs. J Clin Pharm Ther. 1975;18:507-513.
16. Moris L. Rational for patient package inserts. Am J Hosp Pharm. 1978;35:179-184.
17. US Food and Drug Administration. Survey of Consumers' Perception of Patient Package Inserts for Oral Contraceptives. Springfield, VA: National Technical Information Service; 1975.
18. Namikas E, Cheung A, Wilson L, et al. Drug counselling with the aid of a drug education monograph. Hosp Pharm. 1976;11:91-96.
19. Myers E, Calvert E. Information, compliance and side-effects: a study of patients on antidepressant medication. Br J Clin Pharmacol. 1984;17:21-22.
20. Charlotte A, Wagner L. Medication adherence: a literature review. Medscape Pharm. 2005;6(2). Available at: http://www.medscape.com/viewarticle/ 514164. Accessed January 20, 2009.
21. Gianfranceso F, Grogg A, Mahmoud R, et al. Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders (abstract). Clin Ther. 2003;25: 1150-1171.
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (abstract). JAMA. 2001;285: 2486-2497.
23. Crane K, Kirby B, Kooperman D. Patient compliance for psychotropic medications: a group model for an expanding psychiatric inpatient unit. J Psychosoc Nurs Ment Health Serv. 1996;34;8-15.
24. Dolder CR, Lacro JP, Leckband S, et al. Interventions to improve antipsychotic medication adherence: review of recent literature (abstract). J Clin Psychopharmacol. 2003;23:389-399.